22.59
-0.87(-3.71%)
Currency In USD
| Previous Close | 23.46 |
| Open | 23.44 |
| Day High | 23.74 |
| Day Low | 22.05 |
| 52-Week High | 27.64 |
| 52-Week Low | 18.8 |
| Volume | 1.93M |
| Average Volume | 858,596 |
| Market Cap | 971.85M |
| PE | 48.06 |
| EPS | 0.47 |
| Moving Average 50 Days | 23.11 |
| Moving Average 200 Days | 23.94 |
| Change | -0.87 |
If you invested $1000 in Pacira BioSciences, Inc. (PCRX) 10 years ago, it would be worth $403.25 as of February 26, 2026 at a share price of $22.59. Whereas If you bought $1000 worth of Pacira BioSciences, Inc. (PCRX) shares 5 years ago, it would be worth $307.35 as of February 26, 2026 at a share price of $22.59.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Pacira to Report 2025 Financial Results on Thursday February 26, 2026
GlobeNewswire Inc.
Feb 12, 2026 9:01 PM GMT
BRISBANE, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will rep
Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices
GlobeNewswire Inc.
Feb 12, 2026 1:00 PM GMT
BRISBANE, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies, today highlighted new survey findings released by the Voices for No
Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
GlobeNewswire Inc.
Jan 28, 2026 1:00 PM GMT
-- Veteran Executive Brings More Than 25 Years of Clinical Development and Industry Expertise -- BRISBANE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovativ